Shanghai Fosun Pharmaceutical(Group) Co.,Ltd.’s Net Profit Rose 43.1% in First Three Quarters of 2021
Shanghai Fosun Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) (600196.SH) reported a net profit of 3.9 billion yuan in the first three quarters of 2021, up 43.1% year-on-year.
Meanwhile, the company posted 27 billion yuan in revenue, up 22.4% year-on-year.
At the end of the reporting period, it had 90.3 billion yuan in total assets and 41.9 billion yuan in total liabilities, with a liability-to-asset ratio of 46.4%.
This article was automatically produced by Caixin Automation on Nov. 3, 2021.
Download our app to receive breaking news alerts and read the news on the go.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
- MOST POPULAR